Article
The methionine synthase reductase (MTRR) A66G polymorphism is a novel genetic determinant of plasma homocysteine concentrations.
Atherosclerosis - 1 Aug 2001
Gaughan D J, Kluijtmans L A, Barbaux S, McMaster D, Young I S, Yarnell J W, Evans A, Whitehead A S
Abstract excerpt
Epidemiological evidence has revealed that an elevated plasma homocysteine level (hyperhomocysteinemia) confers an increased risk of cardiovascular disease and neural tube defects. Hyperhomocysteinemia is caused by both nutritional (e.g. folate, vitamins B(6) and B(12)) and genetic factors, including functional polymorphisms of key enzymes involved in homocysteine metabolism. One such enzyme, methionine synthase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
